ANGLE – 46p

14 January 2013 - Parsortix cell recovery

Shares in ANGLE have shot up this morning on the news that the company’s Parsortix product can not only capture and count very rare circulating tumour cells from cancer patients but can also recover these cells from the parsortix cassette.  This capability will allow these recovered cells to be analysed and will greatly increase the size of the market for ANGLE.  This is a major development for the group and the shares are a BUY.

cityconfidential © 2019 | T&Cs | Privacy | Wealth Warning